{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:02:31Z","timestamp":1794960151324,"version":"4.9.1"},"reference-count":79,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"50","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Shandong Provincial Medical and Health Science and Technology Project","award":["Number: 2023BJ000011, 2023BJ000016"],"award-info":[{"award-number":["Number: 2023BJ000011, 2023BJ000016"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,12]]},"abstract":"<jats:p>The management and prevention of childhood asthma remain significant challenges. Mendelian randomization (MR) has emerged as a valuable tool for identifying novel therapeutic targets. In response, we conducted a comprehensive, druggable genome-wide MR analysis to elucidate potential therapeutic targets for childhood asthma. Our study integrated genomic data concerning druggable targets, expression quantitative trait loci (eQTLs), and results from genome-wide association studies on childhood asthma. Employing the MR technique, we explored the putative causal links between genes that are targets for drugs and the development of childhood asthma. To validate these causal associations, we utilized reverse MR analyses along with colocalization techniques. Moreover, we performed enrichment analysis, mapped protein interaction networks, and executed drug prediction algorithms and molecular docking studies. These methodologies were applied to gain critical insights that could guide the development of more potent and precise therapeutic agents. We identified 35 druggable genes significantly associated with childhood asthma (including BLVRA, SLC9A3, LYZ, SRPK1, HOXA5, LYVE1, S100A9, ADORA1, RPL13, IL7R, SLFN11, SHMT1, CLN8, TOP1MT, LPAR5, RNASET2, ANK1, H6PD, DSP, CDC25B, VWF, ITK, CACNG6, ITGB7, S100A8, ADAM12, ST14, BMP6, HK2, SYK, ABCA1, ULK4, KBTBD2, SLCO4C1), with BLVRA showing promise as a target. Our research suggests that BLVRA may be a promising target for childhood asthma treatment, aiding in the prioritization of drug development for childhood asthma.<\/jats:p>","DOI":"10.1097\/md.0000000000046718","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T16:01:39Z","timestamp":1765814499000},"page":"e46718","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Systematic druggable genome-wide mendelian randomization identifies therapeutic targets for childhood asthma"],"prefix":"10.1097","volume":"104","author":[{"given":"Junjie","family":"Bi","sequence":"first","affiliation":[{"name":"Department of Gerontology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9530-5072","authenticated-orcid":false,"given":"Jingjing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of HR, Qilu Aerospace Information Research Institute, Jinan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqun","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Gerontology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"Supp 1","key":"R1-20251215","first-page":"1","article-title":"The Global asthma report 2022.","volume":"26","year":"2022","journal-title":"Int J Tuberc Lung Dis"},{"key":"R2-20251215","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s13312-024-3260-7","article-title":"Global initiative for asthma guidelines 2024: an update.","volume":"61","author":"Rajvanshi","year":"2024","journal-title":"Indian Pediatr"},{"key":"R3-20251215","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4168\/aair.2016.8.2.92","article-title":"Environmental exposure and genetic predisposition as risk factors for asthma in China.","volume":"8","author":"Chen","year":"2016","journal-title":"Allergy Asthma Immunol Res"},{"key":"R4-20251215","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3390\/ph18071021","article-title":"Targeted biologic therapies in severe asthma: mechanisms, biomarkers, and clinical applications.","volume":"18","author":"V\u0103ru\u021b","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"key":"R5-20251215","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1056\/NEJMoa2406673","article-title":"Twice-yearly depemokimab in severe asthma with an eosinophilic phenotype.","volume":"391","author":"Jackson","year":"2024","journal-title":"N Engl J Med"},{"key":"R6-20251215","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1164\/rccm.200807-1126OC","article-title":"Severe exacerbations and decline in lung function in asthma.","volume":"179","author":"O\u2019Byrne","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"R7-20251215","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/jama.2017.8372","article-title":"Diagnosis and management of asthma in adults: a review.","volume":"318","author":"McCracken","year":"2017","journal-title":"JAMA"},{"key":"R8-20251215","doi-asserted-by":"crossref","first-page":"e1008489","DOI":"10.1371\/journal.pgen.1008489","article-title":"Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval.","volume":"15","author":"King","year":"2019","journal-title":"PLoS Genet"},{"key":"R9-20251215","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/ng.3314","article-title":"The support of human genetic evidence for approved drug indications.","volume":"47","author":"Nelson","year":"2015","journal-title":"Nat Genet"},{"key":"R10-20251215","doi-asserted-by":"crossref","first-page":"1240517","DOI":"10.3389\/fimmu.2023.1240517","article-title":"Potential drug targets for asthma identified in the plasma and brain through Mendelian randomization analysis.","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"key":"R11-20251215","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1038\/cti.2017.54","article-title":"Lessons from ten years of genome-wide association studies of asthma.","volume":"6","author":"Vicente","year":"2017","journal-title":"Clin Transl Immunology"},{"key":"R12-20251215","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1681\/ASN.2016010098","article-title":"Mendelian randomization as an approach to assess causality using observational data.","volume":"27","author":"Sekula","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R13-20251215","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12920-025-02196-3","article-title":"Blood cell perturbation responses mediate the causal relationship between the gut microbiota and asthma: a bidirectional Mendelian randomization study.","volume":"18","author":"Bi","year":"2025","journal-title":"BMC Med Genomics"},{"key":"R14-20251215","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(12)60110-X","article-title":"The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis.","volume":"379","author":"Swerdlow","year":"2012","journal-title":"Lancet"},{"key":"R15-20251215","doi-asserted-by":"crossref","first-page":"7342","DOI":"10.1038\/s41467-021-26280-1","article-title":"Finding genetically-supported drug targets for Parkinson\u2019s disease using Mendelian randomization of the druggable genome.","volume":"12","author":"Storm","year":"2021","journal-title":"Nat Commun"},{"key":"R16-20251215","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41591-021-01310-z","article-title":"Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19.","volume":"27","author":"Gaziano","year":"2021","journal-title":"Nat Med"},{"key":"R17-20251215","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1038\/s41467-020-16969-0","article-title":"Genetic drug target validation using Mendelian randomisation.","volume":"11","author":"Schmidt","year":"2020","journal-title":"Nat Commun"},{"key":"R18-20251215","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ng.3538","article-title":"Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets.","volume":"48","author":"Zhu","year":"2016","journal-title":"Nat Genet"},{"key":"R19-20251215","doi-asserted-by":"crossref","first-page":"D1144","DOI":"10.1093\/nar\/gkaa1084","article-title":"Integration of the Drug-Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts.","volume":"49","author":"Freshour","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"R20-20251215","doi-asserted-by":"crossref","first-page":"eaag1166","DOI":"10.1126\/scitranslmed.aag1166","article-title":"The druggable genome and support for target identification and validation in drug development.","volume":"9","author":"Finan","year":"2017","journal-title":"Sci Transl Med"},{"key":"R21-20251215","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1136\/jnnp-2023-331142","article-title":"Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer\u2019s disease.","volume":"94","author":"Su","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R22-20251215","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s10194-024-01805-3","article-title":"Identifying therapeutic target genes for migraine by systematic druggable genome-wide Mendelian randomization.","volume":"25","author":"Zhang","year":"2024","journal-title":"J Headache Pain"},{"key":"R23-20251215","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13059-020-02248-0","article-title":"The variant call format provides efficient and robust storage of GWAS summary statistics.","volume":"22","author":"Lyon","year":"2021","journal-title":"Genome Biol"},{"key":"R24-20251215","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population.","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"R25-20251215","doi-asserted-by":"crossref","first-page":"e34408","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome.","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"key":"R26-20251215","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1093\/ije\/dyq151","article-title":"Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants.","volume":"40","author":"Pierce","year":"2011","journal-title":"Int J Epidemiol"},{"key":"R27-20251215","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10654-015-0011-z","article-title":"Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors.","volume":"30","author":"Burgess","year":"2015","journal-title":"Eur J Epidemiol"},{"key":"R28-20251215","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1093\/ije\/dyx191","article-title":"A note on the use of Egger regression in Mendelian randomization studies.","volume":"46","author":"Slob","year":"2017","journal-title":"Int J Epidemiol"},{"key":"R29-20251215","doi-asserted-by":"crossref","first-page":"1366290","DOI":"10.3389\/fendo.2024.1366290","article-title":"Based on systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for diabetes.","volume":"15","author":"Li","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R30-20251215","doi-asserted-by":"crossref","first-page":"e1004383","DOI":"10.1371\/journal.pgen.1004383","article-title":"Bayesian test for colocalisation between pairs of genetic association studies using summary statistics.","volume":"10","author":"Giambartolomei","year":"2014","journal-title":"PLoS Genet"},{"key":"R31-20251215","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.ajhg.2022.04.001","article-title":"Combining evidence from Mendelian randomization and colocalization: review and comparison of approaches.","volume":"109","author":"Zuber","year":"2022","journal-title":"Am J Hum Genet"},{"key":"R32-20251215","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1186\/s12885-024-12449-6","article-title":"Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer.","volume":"24","author":"Song","year":"2024","journal-title":"BMC Cancer"},{"key":"R33-20251215","doi-asserted-by":"crossref","first-page":"104494","DOI":"10.1016\/j.ebiom.2023.104494","article-title":"Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses.","volume":"89","author":"Chen","year":"2023","journal-title":"EBioMedicine"},{"key":"R34-20251215","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12933-022-01613-6","article-title":"Evaluating the impact of glucokinase activation on risk of cardiovascular disease: a Mendelian randomisation analysis.","volume":"21","author":"Wang","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"R35-20251215","doi-asserted-by":"crossref","first-page":"e034749","DOI":"10.1161\/JAHA.124.034749","article-title":"Systematic druggable genome-wide mendelian randomization identifies therapeutic targets for functional outcome after ischemic stroke.","volume":"13","author":"Zhang","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"R36-20251215","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters.","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"R37-20251215","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest.","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"R38-20251215","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1093\/bioinformatics\/btv313","article-title":"DSigDB: drug signatures database for gene set analysis.","volume":"31","author":"Yoo","year":"2015","journal-title":"Bioinformatics"},{"key":"R39-20251215","doi-asserted-by":"crossref","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","article-title":"PubChem 2023 update.","volume":"51","author":"Kim","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"R40-20251215","doi-asserted-by":"crossref","first-page":"W159","DOI":"10.1093\/nar\/gkac394","article-title":"CB-Dock2: improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting.","volume":"50","author":"Liu","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"R41-20251215","doi-asserted-by":"crossref","first-page":"bbac087","DOI":"10.1093\/bib\/bbac087","article-title":"FitDock: protein-ligand docking by template fitting.","volume":"23","author":"Yang","year":"2022","journal-title":"Brief Bioinform"},{"key":"R42-20251215","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/ahg.12179","article-title":"Genetic variations in bilirubin metabolism genes and their association with unconjugated hyperbilirubinemia in adults.","volume":"81","author":"Chiddarwar","year":"2017","journal-title":"Ann Hum Genet"},{"key":"R43-20251215","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/aje\/kwt248","article-title":"Neonatal bilirubin levels and childhood asthma in the US Collaborative Perinatal Project, 1959-1965.","volume":"178","author":"Huang","year":"2013","journal-title":"Am J Epidemiol"},{"key":"R44-20251215","doi-asserted-by":"crossref","first-page":"e20180662","DOI":"10.1542\/peds.2018-0662","article-title":"Hyperbilirubinemia, phototherapy, and childhood asthma.","volume":"142","author":"Kuzniewicz","year":"2018","journal-title":"Pediatrics"},{"key":"R45-20251215","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.medj.2024.07.021","article-title":"Bilirubin metabolism in early life and respiratory health during preschool age: a combined analysis of two independent birth cohorts.","volume":"5","author":"Kim","year":"2024","journal-title":"Med"},{"key":"R46-20251215","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jaci.2021.03.046","article-title":"Nudging the bilirubin dial to protect against asthma development.","volume":"148","author":"Petersen","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"R47-20251215","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1620\/tjem.199.193","article-title":"Transient relief of asthma symptoms during jaundice: a possible beneficial role of bilirubin.","volume":"199","author":"Ohrui","year":"2003","journal-title":"Tohoku J Exp Med"},{"key":"R48-20251215","first-page":"382","article-title":"The protective effect of bilirubin in the establishment of asthma models.","volume":"36","author":"Fan","year":"2016","journal-title":"Modern Immunol"},{"key":"R49-20251215","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fphar.2012.00030","article-title":"Direct antioxidant properties of bilirubin and biliverdin. Is there a role for biliverdin reductase?","volume":"3","author":"Jansen","year":"2012","journal-title":"Front Pharmacol"},{"key":"R50-20251215","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1542\/peds.113.6.1776","article-title":"Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle.","volume":"113","author":"Sedlak","year":"2004","journal-title":"Pediatrics"},{"key":"R51-20251215","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1126\/science.3029864","article-title":"Bilirubin is an antioxidant of possible physiological importance.","volume":"235","author":"Stocker","year":"1987","journal-title":"Science"},{"key":"R52-20251215","first-page":"76","article-title":"Research progress of relationship between serum bilirubin and coronary heart disease.","volume":"44","author":"Lian","year":"2016","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"R53-20251215","doi-asserted-by":"crossref","first-page":"106520","DOI":"10.1016\/j.intimp.2020.106520","article-title":"Physiological concentrations of bilirubin control inflammatory response by inhibiting NF-\u03baB and inflammasome activation.","volume":"84","author":"Li","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"R54-20251215","first-page":"8","article-title":"Hydrogen peroxide activation of endothelial cell-associated MMPs during VCAM-1-dependent leukocyte migration.","volume":"52","author":"Cook-Mills","year":"2006","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"R55-20251215","first-page":"189","article-title":"Changes and significance of bilirubin levels in respiratory inflammatory diseases.","volume":"50","author":"Wei","year":"2019","journal-title":"J Shanxi Med Univ"},{"key":"R56-20251215","first-page":"481","article-title":"Clinical significance of serum bilirubin in chronic obstructive pulmonary disease.","volume":"41","author":"Cheng","year":"2021","journal-title":"Int J Respir"},{"key":"R57-20251215","doi-asserted-by":"crossref","first-page":"18566","DOI":"10.1021\/acsanm.4c02015","article-title":"Bilirubin nanoparticles alleviate sepsis-inducedacute lung injury by protecting pulmonary endothelia glycocalyx and reducing inflammation.","volume":"7","author":"Xia","year":"2024","journal-title":"ACS Appl Nano Mater"},{"key":"R58-20251215","first-page":"1925","article-title":"Research progress on the role of bilirubin in inflammatory bowel disease.","volume":"42","author":"Shi","year":"2022","journal-title":"Basic Clin Med"},{"key":"R59-20251215","first-page":"144","article-title":"Advances in genetic research related to the metabolic pathways of unconjugated hyperbilirubinemia in newborns.","volume":"34","author":"Bu","year":"2019","journal-title":"Chin J Neonatol"},{"key":"R60-20251215","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.3928\/19382359-20230209-01","article-title":"The latest national asthma education and prevention program guidelines: a review for the busy pediatrician.","volume":"52","author":"Ni","year":"2023","journal-title":"Pediatr Ann"},{"key":"R61-20251215","first-page":"1964","article-title":"Analysis on the management of type 2 inflammatory asthma from the guideline of global strategy for asthma management and prevention.","volume":"57","author":"Guan","year":"2023","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"R62-20251215","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/adc.79.5.405","article-title":"Randomised controlled trial of aminophylline for severe acute asthma.","volume":"79","author":"Yung","year":"1998","journal-title":"Arch Dis Child"},{"key":"R63-20251215","doi-asserted-by":"crossref","first-page":"e0159965","DOI":"10.1371\/journal.pone.0159965","article-title":"Aminophylline dosage in asthma exacerbations in children: a systematic review.","volume":"11","author":"Cooney","year":"2016","journal-title":"PLoS One"},{"key":"R64-20251215","doi-asserted-by":"crossref","first-page":"200081","DOI":"10.1183\/20734735.0081-2020","article-title":"Treating acute severe asthma attacks in children: using aminophylline.","volume":"16","author":"Aralihond","year":"2020","journal-title":"Breathe (Sheff)"},{"key":"R65-20251215","first-page":"CD001276","article-title":"Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators.","volume":"2005","author":"Mitra","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"R66-20251215","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/DDDT.S156509","article-title":"Efficacy and side effects of intravenous theophylline in acute asthma: a systematic review and meta-analysis.","volume":"12","author":"Mahemuti","year":"2018","journal-title":"Drug Des Devel Ther"},{"key":"R67-20251215","first-page":"730","article-title":"The expresion of heme oxygenase-1 in rats liver induced by hemin.","volume":"8","author":"Huang","year":"2008","journal-title":"Chin J Trop Med"},{"key":"R68-20251215","doi-asserted-by":"crossref","first-page":"5936","DOI":"10.4049\/jimmunol.177.9.5936","article-title":"Heme oxygenase-1-mediated CD4+CD25high regulatory T cells suppress allergic airway inflammation.","volume":"177","author":"Xia","year":"2006","journal-title":"J Immunol"},{"key":"R69-20251215","doi-asserted-by":"crossref","first-page":"34612","DOI":"10.1074\/jbc.M113.494369","article-title":"Heme oxygenase-1 exerts a protective role in ovalbumin-induced neutrophilic airway inflammation by inhibiting Th17 cell-mediated immune response.","volume":"288","author":"Zhang","year":"2013","journal-title":"J Biol Chem"},{"key":"R70-20251215","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1111\/all.13216","article-title":"Heme oxygenase-1 directly binds STAT3 to control the generation of pathogenic Th17 cells during neutrophilic airway inflammation.","volume":"72","author":"Lin","year":"2017","journal-title":"Allergy"},{"key":"R71-20251215","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/imm.12564","article-title":"Heme oxygenase-1 inhibits basophil maturation and activation but promotes its apoptosis in T helper type 2-mediated allergic airway inflammation.","volume":"147","author":"Zhong","year":"2016","journal-title":"Immunology"},{"key":"R72-20251215","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3390\/biomedicines12040898","article-title":"The pharmacological effect of hemin in inflammatory-related diseases: a systematic review.","volume":"12","author":"Estarreja","year":"2024","journal-title":"Biomedicines"},{"key":"R73-20251215","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0140-6736(22)01485-4","article-title":"Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes.","volume":"400","author":"Bos","year":"2022","journal-title":"Lancet"},{"key":"R74-20251215","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/SHK.0000000000002101","article-title":"Hemin attenuated lps-induced acute lung injury in mice via protecting pulmonary epithelial barrier and regulating HO-1\/NLRP3-mediated pyroptosis.","volume":"59","author":"Cheng","year":"2023","journal-title":"Shock"},{"key":"R75-20251215","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12967-016-0793-0","article-title":"Induction of heme oxygenase-1 by hemin protects lung against orthotopic autologous liver transplantation-induced acute lung injury in rats.","volume":"14","author":"Chi","year":"2016","journal-title":"J Transl Med"},{"key":"R76-20251215","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/mi.2015.39","article-title":"Tissue heme oxygenase-1 exerts anti-inflammatory effects on LPS-induced pulmonary inflammation.","volume":"9","author":"Konrad","year":"2016","journal-title":"Mucosal Immunol"},{"key":"R77-20251215","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.3390\/cells11182771","article-title":"Forskolin, an adenylcyclase\/cAMP\/CREB signaling activator restoring myelin-associated oligodendrocyte destruction in experimental ethidium bromide model of multiple sclerosis.","volume":"11","author":"Kapoor","year":"2022","journal-title":"Cells"},{"key":"R78-20251215","first-page":"1773","article-title":"Research progress in regulating cAMP pathway to prevent and treat chronic obstructive pulmonary disease.","volume":"38","author":"Liang","year":"2022","journal-title":"Chin Pharmacol Bull"},{"key":"R79-20251215","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/hep.20154","article-title":"5\u2019-methylthioadenosine modulates the inflammatory response to endotoxin in mice and in rat hepatocytes.","volume":"39","author":"Hevia","year":"2004","journal-title":"Hepatology"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046718","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T16:01:49Z","timestamp":1765814509000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":79,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046718","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"2025-08-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}